BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18937732)

  • 1. Progress in TRALI.
    Wallis JP
    Transfus Med; 2008 Oct; 18(5):273-5. PubMed ID: 18937732
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening of multiparous women to avoid transfusion-related acute lung injury: a single centre experience.
    Sachs UJ; Link E; Hofmann C; Wasel W; Bein G
    Transfus Med; 2008 Dec; 18(6):348-54. PubMed ID: 19140817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing TRALI: ladies first, what follows?
    Vlaar AP; Binnekade JM; Schultz MJ; Juffermans NP; Koopman MM
    Crit Care Med; 2008 Dec; 36(12):3283-4; author reply 3284. PubMed ID: 19020453
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibody-mediated (immune) transfusion-related acute lung injury.
    Bux J
    Vox Sang; 2011 Jan; 100(1):122-8. PubMed ID: 21175662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How much residual plasma may cause TRALI?
    Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
    Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transfusion-related acute lung injury].
    Vlaar AP; Juffermans NP
    Ned Tijdschr Geneeskd; 2013; 157(11):A5524. PubMed ID: 23484511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of donor HLA antibody strength to the development of transfusion-related acute lung injury.
    Hashimoto S; Nakajima F; Kamada H; Kawamura K; Satake M; Tadokoro K; Okazaki H
    Transfusion; 2010 Dec; 50(12):2582-91. PubMed ID: 20667042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors.
    Reil A; Keller-Stanislawski B; Günay S; Bux J
    Vox Sang; 2008 Nov; 95(4):313-7. PubMed ID: 19138261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and severity of transfusion-related acute lung injury--German haemovigilance data (2006-2007).
    Keller-Stanislawski B; Reil A; Günay S; Funk MB
    Vox Sang; 2010 Jan; 98(1):70-7. PubMed ID: 19671122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allo-exposure status and leucocyte antibody positivity of blood donors show a similar relation with TRALI.
    Middelburg RA; Beckers EA; Porcelijn L; Lardy N; Wiersum-Osselton JC; Schipperus MR; Vrielink H; Briët E; van der Bom JG
    Transfus Med; 2012 Apr; 22(2):128-32. PubMed ID: 22380759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood donors implicated in transfusion-related acute lung injury with patient-specific HLA antibodies are more broadly sensitized to HLA antigens compared to other blood donors.
    Saw CL; Hannach B; Petrazsko T; Nickerson P
    Transfusion; 2013 Mar; 53(3):518-25. PubMed ID: 22738429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines.
    Lucas G; Win N; Calvert A; Green A; Griffin E; Bendukidze N; Hopkins M; Browne T; Poles A; Chapman C; Massey E
    Vox Sang; 2012 Jul; 103(1):10-7. PubMed ID: 22150747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation and outcomes of a transfusion-related acute lung injury surveillance programme and study of HLA/HNA alloimmunisation in blood donors.
    Porretti L; Cattaneo A; Coluccio E; Mantione E; Colombo F; Mariani M; Bottelli G; Mazzucchelli S; Pappalettera M; Speranza T; Migliari M; Cambié G; Prati D; Rebulla P
    Blood Transfus; 2012 Jul; 10(3):351-9. PubMed ID: 22395353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-mediated transfusion-related acute lung injury; from discovery to prevention.
    Peters AL; Van Stein D; Vlaar AP
    Br J Haematol; 2015 Sep; 170(5):597-614. PubMed ID: 25921271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of transfusion-related acute lung injury (TRALI): anti-leukocyte antibodies.
    Curtis BR; McFarland JG
    Crit Care Med; 2006 May; 34(5 Suppl):S118-23. PubMed ID: 16617255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor screening as a TRALI risk reduction strategy.
    Murphy MF; Navarrete C; Massey E
    Transfusion; 2009 Sep; 49(9):1779-82. PubMed ID: 19735501
    [No Abstract]   [Full Text] [Related]  

  • 17. [The immunological conflict in the transfusion-related acute lung injury or TRALI].
    Drouet C; Khoy K; Masson D; Bardy B; Giannoli C; Dubois V
    Transfus Clin Biol; 2011 Apr; 18(2):224-9. PubMed ID: 21470890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transfusion-related acute lung injury].
    Añón JM; García de Lorenzo A; Quintana M; González E; Bruscas MJ
    Med Intensiva; 2010 Mar; 34(2):139-49. PubMed ID: 20156708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of leucocyte antibodies in the Dutch donor population.
    Middelburg RA; Porcelijn L; Lardy N; Briët E; Vrielink H
    Vox Sang; 2011 Apr; 100(3):327-35. PubMed ID: 20946548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leucocyte antibodies in blood donors and a look back on recipients of their blood components.
    Maślanka K; Michur H; Zupańska B; Uhrynowska M; Nowak J
    Vox Sang; 2007 Apr; 92(3):247-9. PubMed ID: 17348874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.